News: MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

3.77EUR
9:11am EDT
Price Change (% chg)

€-0.01 (-0.19%)
Prev Close
€3.78
Open
€3.80
Day's High
€3.86
Day's Low
€3.76
Volume
38,807
Avg. Vol
76,153
52-wk High
€5.29
52-wk Low
€2.65

Search Stocks
Select another date:

Fri, Oct 10 2014

BRIEF-Mdxhealth announces positive trial data for Confirmmdx

* Announces positive data from study confirming ability of Confirmmdx genes to identify prostate cancer aggressiveness in diagnostic biopsies

BRIEF-MdxHealth says ConfirmMDx for postate cancer test qualifies for medicare coverage

* Mdxhealth's confirmmdx for prostate cancer test qualifies for medicare coverage effective november 3, 2014

BRIEF-MDxHealth first-half revenue rises 21 pct

* Revenue increased 21 pct to $4.8 million in H1 2014 over $4 million in H1 2013

BRIEF-MDxHealth signs co-marketing agreement for prostate cancer test

* MDxHealth and American Pathology Partners announce marketing agreement for ConfirmMDx for prostate cancer Source text for Eikon: Further company coverage:

Select another date:
Search Stocks